Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1yl)-4-(1H-indol-3-yl) pyrrolidine-2, 5-dione

EU orphan designation number: EU/3/09/678
Active ingredient: (-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1yl)-4-(1H-indol-3-yl) pyrrolidine-2, 5-dione
Indication: Treatment of soft tissue sarcoma
Sponsor: Gregory Fryer Associates Ltd
30 St Thomas Place, Cambridgeshire Business Park, Ely, Cambridgeshire CB7 4EX, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2009 Centralised Orphan - Designation EMEA/OD/036/09 (2009)7857 of 08/10/2009